<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ920120-0030</DOCNO><DOCID>920120-0030.</DOCID><HL>   Technology Brief -- Merck andamp; Co.:   Certain U.S. Health Centers   To Receive Low-Cost Drugs</HL><DATE>01/20/92</DATE><SO>WALL STREET JOURNAL (J), PAGE B6</SO><CO>   MRK</CO><MS>FINANCIAL (FIN)CONSUMER NON-CYCLICAL (NCY)</MS><IN>DRUG MANUFACTURERS (DRG)INSURANCE (INS)</IN><GV>FEDERAL GOVERNMENT (FDL)</GV><RE>NEW JERSEY (NJ)NORTH AMERICA (NME)UNITED STATES (US)</RE><LP>   Merck andamp; Co., Rahway, N.J., said that it will reduce thecost of prescription drugs it sells to certain federallyfunded health centers for the poor, becoming the second majordrug company to announce such a program this year.   Merck said that it will offer discounts of at least 12.5%,comparable to the federally mandated minimum discounts itprovides to state Medicaid programs, which providehealth-care coverage for the poor.</LP><TEXT>   Earlier this month, Bristol-Myers Squibb Co. announced asimilar program.   Drug companies have been under pressure to rein in thesharp rise in pharmaceutical prices. If other companiesfollow the lead of Merck and Bristol-Myers, federal outlaysfor prescription drugs could be reduced by several hundredmillion dollars a year.   Merck's plan, which will apply to many federally fundedhealth centers that serve approximately six million poor anduninsured people, is set to begin on May 1.</TEXT></DOC>